WELL HEALTH TECHNOLOGIES COR (WELL.CA) Stock Fundamental Analysis
Canada - TSX:WELL - CA94947L1022 - Common Stock
4.72 CAD
+0.02 (+0.43%)
Overall WELL gets a fundamental rating of 3 out of 10. We evaluated WELL against 15 industry peers in the Health Care Providers & Services industry. WELL has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, WELL is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
WELL had negative earnings in the past year.
WELL had a positive operating cash flow in the past year.
In multiple years WELL reported negative net income over the last 5 years.
WELL had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
WELL has a Return On Assets of -6.37%. This is in the lower half of the industry: WELL underperforms 60.00% of its industry peers.
WELL's Return On Equity of -15.57% is in line compared to the rest of the industry. WELL outperforms 46.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -6.37% | ||
| ROE | -15.57% | ||
| ROIC | N/A |
ROA(3y)0.64%
ROA(5y)-0.59%
ROE(3y)1.32%
ROE(5y)-0.98%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
WELL has a Gross Margin (39.21%) which is comparable to the rest of the industry.
In the last couple of years the Gross Margin of WELL has grown nicely.
WELL does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 39.21% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.09%
GM growth 5Y3.31%
2. Health
2.1 Basic Checks
WELL does not have a ROIC to compare to the WACC, probably because it is not profitable.
WELL has more shares outstanding than it did 1 year ago.
WELL has more shares outstanding than it did 5 years ago.
WELL has a better debt/assets ratio than last year.
2.2 Solvency
WELL has an Altman-Z score of 1.07. This is a bad value and indicates that WELL is not financially healthy and even has some risk of bankruptcy.
WELL has a Altman-Z score of 1.07. This is comparable to the rest of the industry: WELL outperforms 53.33% of its industry peers.
WELL has a Debt/Equity ratio of 0.68. This is a neutral value indicating WELL is somewhat dependend on debt financing.
The Debt to Equity ratio of WELL (0.68) is better than 73.33% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.68 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.07 |
ROIC/WACCN/A
WACC8.28%
2.3 Liquidity
WELL has a Current Ratio of 0.93. This is a bad value and indicates that WELL is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.93, WELL is in the better half of the industry, outperforming 73.33% of the companies in the same industry.
A Quick Ratio of 0.92 indicates that WELL may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.92, WELL is in the better half of the industry, outperforming 80.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.93 | ||
| Quick Ratio | 0.92 |
3. Growth
3.1 Past
The earnings per share for WELL have decreased strongly by -221.43% in the last year.
Looking at the last year, WELL shows a very strong growth in Revenue. The Revenue has grown by 20.36%.
Measured over the past years, WELL shows a very strong growth in Revenue. The Revenue has been growing by 94.78% on average per year.
EPS 1Y (TTM)-221.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-90.7%
Revenue 1Y (TTM)20.36%
Revenue growth 3Y44.9%
Revenue growth 5Y94.78%
Sales Q2Q%46.69%
3.2 Future
The Earnings Per Share is expected to grow by 15.87% on average over the next years. This is quite good.
WELL is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 15.88% yearly.
EPS Next Y-80.96%
EPS Next 2Y3.84%
EPS Next 3Y13.5%
EPS Next 5Y15.87%
Revenue Next Year43.56%
Revenue Next 2Y25.75%
Revenue Next 3Y19.49%
Revenue Next 5Y15.88%
3.3 Evolution
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
WELL reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
With a Price/Forward Earnings ratio of 29.18, WELL can be considered very expensive at the moment.
Based on the Price/Forward Earnings ratio, WELL is valued a bit cheaper than 73.33% of the companies in the same industry.
WELL is valuated rather expensively when we compare the Price/Forward Earnings ratio to 22.77, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 29.18 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of WELL is on the same level as its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 25.29 |
4.3 Compensation for Growth
WELL's earnings are expected to grow with 13.50% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y3.84%
EPS Next 3Y13.5%
5. Dividend
5.1 Amount
WELL does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
TSX:WELL (9/15/2025, 7:00:00 PM)
4.72
+0.02 (+0.43%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners7.41%
Inst Owner ChangeN/A
Ins Owners8.56%
Ins Owner ChangeN/A
Market Cap1.20B
Analysts81
Price Target7.82 (65.68%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-368.63%
Min EPS beat(2)-696.08%
Max EPS beat(2)-41.18%
EPS beat(4)0
Avg EPS beat(4)-1069.61%
Min EPS beat(4)-3335.29%
Max EPS beat(4)-41.18%
EPS beat(8)2
Avg EPS beat(8)1698.56%
EPS beat(12)3
Avg EPS beat(12)1044.26%
EPS beat(16)3
Avg EPS beat(16)671.21%
Revenue beat(2)1
Avg Revenue beat(2)0.17%
Min Revenue beat(2)-1.25%
Max Revenue beat(2)1.59%
Revenue beat(4)1
Avg Revenue beat(4)-3.16%
Min Revenue beat(4)-12.61%
Max Revenue beat(4)1.59%
Revenue beat(8)4
Avg Revenue beat(8)-0.94%
Revenue beat(12)6
Avg Revenue beat(12)-0.37%
Revenue beat(16)10
Avg Revenue beat(16)0.69%
PT rev (1m)0.23%
PT rev (3m)0.47%
EPS NQ rev (1m)26.08%
EPS NQ rev (3m)191.38%
EPS NY rev (1m)-86.98%
EPS NY rev (3m)-86.98%
Revenue NQ rev (1m)0.22%
Revenue NQ rev (3m)28.01%
Revenue NY rev (1m)0.55%
Revenue NY rev (3m)1.83%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 29.18 | ||
| P/S | 1.09 | ||
| P/FCF | N/A | ||
| P/OCF | 258.44 | ||
| P/B | 1.45 | ||
| P/tB | N/A | ||
| EV/EBITDA | 25.29 |
EPS(TTM)-0.51
EYN/A
EPS(NY)0.16
Fwd EY3.43%
FCF(TTM)-0.07
FCFYN/A
OCF(TTM)0.02
OCFY0.39%
SpS4.32
BVpS3.26
TBVpS-2.58
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -6.37% | ||
| ROE | -15.57% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 39.21% | ||
| FCFM | N/A |
ROA(3y)0.64%
ROA(5y)-0.59%
ROE(3y)1.32%
ROE(5y)-0.98%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.09%
GM growth 5Y3.31%
F-Score2
Asset Turnover0.54
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.68 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 8.34 | ||
| Cap/Depr | 25.5% | ||
| Cap/Sales | 1.94% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 6.83% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.93 | ||
| Quick Ratio | 0.92 | ||
| Altman-Z | 1.07 |
F-Score2
WACC8.28%
ROIC/WACCN/A
Cap/Depr(3y)15.79%
Cap/Depr(5y)16.17%
Cap/Sales(3y)1.31%
Cap/Sales(5y)1.41%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-221.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-90.7%
EPS Next Y-80.96%
EPS Next 2Y3.84%
EPS Next 3Y13.5%
EPS Next 5Y15.87%
Revenue 1Y (TTM)20.36%
Revenue growth 3Y44.9%
Revenue growth 5Y94.78%
Sales Q2Q%46.69%
Revenue Next Year43.56%
Revenue Next 2Y25.75%
Revenue Next 3Y19.49%
Revenue Next 5Y15.88%
EBIT growth 1Y-144.86%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year269.34%
EBIT Next 3Y60.62%
EBIT Next 5Y41.94%
FCF growth 1Y-124.66%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-93.87%
OCF growth 3Y-22.85%
OCF growth 5YN/A